Get the Stockscreener App
4.29
0.92%
-0.04
After Hours:
4.29
Quanterix Corp stock is traded at $4.29, with a volume of 476.42K.
It is down -0.92% in the last 24 hours and up +30.00% over the past month.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
See More
Previous Close:
$4.33
Open:
$4.31
24h Volume:
476.42K
Relative Volume:
0.38
Market Cap:
$202.08M
Revenue:
$144.98M
Net Income/Loss:
$-104.19M
P/E Ratio:
-1.8124
EPS:
-2.367
Net Cash Flow:
$-82.90M
1W Performance:
-5.51%
1M Performance:
+30.00%
6M Performance:
-34.50%
1Y Performance:
-38.54%
1-Day Range:
$4.1524
$4.45
1-Week Range:
$4.115
$4.50
52-Week Range:
$2.395
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Name
Quanterix Corp
Sector
Industry
Phone
617-301-9400
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
4.29 | 203.50M | 144.98M | -104.19M | -82.90M | -2.367 |
ABT
Abbott Laboratories
|
95.63 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
324.73 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.06 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.60 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
95.18 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-01-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-25-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-08-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| May-23-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-15-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-09-22 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-09-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-02-22 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-04-21 | Initiated | Goldman | Sell |
View All
Quanterix Corp Stock (QTRX) Latest News
TRIB, QTRX, RCON: Why these stocks are surging after-hours today - MSN
QTRX Forecast — Price Target — Prediction for 2027 - TradingView
Quanterix Corp sets out growth plans, shares trade on Nasdaq - AD HOC NEWS
Quanterix Stock Is Popping In Pre-Market: Here's Why - Sahm
Quanterix Corp (QTRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Form 4 Quanterix Corp For: 23 June - Investing.com UK
TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today - TradingView
Form 4 Quanterix Corp For: 23 June By Investing.com - Investing.com Nigeria
Quanterix (QTRX) CFO adds stock as RSUs vest and shares withheld - Stock Titan
Quanterix (QTRX) CFO Jason Faessler files initial Form 3 ownership - Stock Titan
Quanterix Corp (QTRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
QTRXQuanterix Corp Volatility & Greeks - Finviz
Quanterix Corp (QTRX) Institutional Confidence - TradingKey
Quanterix Corp (QTRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Quanterix Corp (QTRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Quanterix Corp (QTRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Quanterix Corp (QTRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Quanterix Corp (QTRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Quanterix Corp (QTRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Quanterix (QTRX) CTO exercises 1,558 RSUs; 467 shares withheld for taxes - Stock Titan
Biotech Quanterix gives new staff 336,804 stock units over 4 years - Stock Titan
Quanterix CCO Benjamin Meadows buys $9,695 in company stock By Investing.com - Investing.com Nigeria
Quanterix (QTRX) Chief Commercial Officer buys 3,500 shares in open-market trade - Stock Titan
Quanterix (QTRX) CCO Benjamin Meadows reports options, RSUs and PSUs in Form 3 - Stock Titan
Quanterix (NASDAQ: QTRX) investors back pay, auditors but reject equity plan - Stock Titan
Quanterix stock falls on CFO appointment announcement - Investing.com
Quanterix Appoints Jason Faessler as New CFO to Drive Strategic Growth in Life Sciences Industry - Minichart
Quanterix stock falls on CFO appointment announcement By Investing.com - Investing.com Nigeria
Quanterix appoints Jason Faessler as CFO and Treasurer - TradingView
Quanterix names Jason Faessler as chief financial officer - Investing.com
Jason Faessler joins Quanterix (QTRX) as Chief Financial Officer and Treasurer - Stock Titan
From Bruker to Quanterix: Jason Faessler takes over as CFO - Stock Titan
Earnings call transcript: Quanterix Q1 2026 EPS beats, revenue misses - Investing.com
Quanterix Q1 2026 slides: $85M synergies offset organic decline - Investing.com
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Quanterix appoints Geoff Albrecht to lead diagnostics unit - Investing.com
Former Quest exec Geoff Albrecht to lead Quanterix Alzheimer’s diagnostics - Stock Titan
Quanterix to Take Part in Conference - Baystreet.ca
Quanterix CEO to host June 9 fireside chat at Goldman Sachs healthcare event - Stock Titan
EDGAR Filing Documents for 0001503274-26-000011 - SEC.gov
Quanterix (QTRX) CTO exercises 130 RSUs, with 39 shares used for taxes - Stock Titan
QTRX Technical Analysis & Stock Price Forecast - Intellectia AI
QTRX News | QUANTERIX CORP (NASDAQ:QTRX) - ChartMill
Quanterix Corporation Appoints Anthony Catalano as Chief Operations Officer – Employment Agreement Details and Corporate Information - Minichart
Quanterix names Anthony Catalano COO; Michael Miller becomes Chief Technology and Products Officer - TradingView
New Quanterix COO Anthony Catalano gets 141,330 restricted stock units - Stock Titan
Quanterix (QTRX) Edges Higher on Light Volume, Holds Above Key SupportBear Pennant - newsline.com
Quanterix targets $169M-$174M 2026 revenue while preparing HD-X IVD filing in 2027 - MSN
Quanterix (QTRX) CFO reports RSU vesting and tax-withholding share dispositions - Stock Titan
Quanterix (QTRX) CTO gains 1,558 shares from RSU vesting, 467 withheld for tax - Stock Titan
Quanterix Corp Stock (QTRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quanterix Corp Stock (QTRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sriram Vandana | Chief Financial Officer |
Sep 12 '25 |
Buy |
4.79 |
4,150 |
19,878 |
87,200 |
2.62%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):